FARMINGDALE, N.Y., Sept. 28 /PRNewswire-FirstCall/ -- Cemtrex, Inc.
(OTC: CTEX) announced that it has received Performance Test Protocol
approval from NYDEC for its laser-based Continuous Opacity Monitoring
system at a major medical center in Brooklyn, NY.
"Our EPA3 laser opacity monitor is being installed in the boiler
exhaust duct inside the hospital building conforming to the new PS-1
regulations," said Mr. Aron Govil, President and CEO of Cemtrex. "After
carefully examining the location, we determined the proper configuration
that would comply with the new PS-1 regulations and get the NYDEC
approval." This hospital is a landmark in the Brooklyn area and Cemtrex is
installing the complete EPA reporting software package for the laser
opacity monitor designed to monitor the particulate emissions from the
boiler exhaust flue gases.
Cemtrex provides turnkey services for carbon creation projects from
abatement of greenhouse gases pursuant to the Kyoto Protocol. Cemtrex,
through its MIP-Ducon division, is engaged in manufacturing and selling the
most advanced and custom-engineered instruments for emission monitoring.
The Company's products are sold to power plants, refineries, chemical
plants, cement plants and other industries, including federal and state
Safe Harbor Statement
This press release contains forward-looking statements. Actual results
could differ materially from those projected in the forward-looking
statements as a result of a number of risks and uncertainties. Statements
made herein are as of the date of this press release and should not be
relied upon as of any subsequent date.
For further information please contact:
19 Engineers Lane
Farmingdale, NY 11735
This release was issued through eReleases(TM). For more information,
SOURCE Cemtrex, Inc.